RXRX

#2015
Recursion Pharmaceuticals, Inc. Class A Common Stock
3.54 USD
+3.51%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
3.54
3.54
년간 변동
2.80
7.18
일일 변동
+3.51%
월간 변동
+2.61%
6달 변화
-41.29%
년간 변동율
-36.22%
이전 종가
3.42
Open
3.54
Bid
Ask
Low
3.54
High
3.54
양
103
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 1.87 B
  • Employee 600
  • Founded 2013
  • CEO Najat Khan
  • Website www.recursion.com
  • Headquarter Delaware, United States
  • FIGI BBG00PQ4XJ45
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.84
Price to sales ratio
24.5

Recursion Pharmaceuticals Inc - Class A

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

뉴스